Boston Sci's Abele won't stand for reelection; TNInvestco partners to help launch med device group;

> Boston Scientific co-founder John Abele will not be standing for reelection to the board of the Natick-based medical device giant, according to a regulatory filing. Report

> TriStar Technology Fund and Limestone Fund, two original recipients of funding through the state's TNInvestco program, are joining together to create a new medical-device company. Newly formed Device Innovation Group LLC will partner with MDI Partners LLC, which has offices in Florida and Oregon, to work with universities in introducing new medical devices in underserved markets. Item

> In response to news article published earlier this week regarding Radient Pharmaceuticals, RPC confirmed its post-launch trial "Evaluation of AMDL-ELISA DR-70" (RPC's Onko-Sure in vitro diagnostic cancer test) is on track. Radient Pharmaceuticals release

> David Lucchino, CEO of Cambridge-based Semprus BioSciences, has been elected to the board of directors of the trade association Advanced Medical Technology Association (AdvaMed). Article

> Hospira has snagged Allergan President F. Michael Ball as its new CEO. The specialty pharma's current chief and founder, Christopher Begley, will move upstairs to the executive chairman's job. Ball takes the reins March 28. Item

> A regenerative medicine breakthrough involving urinary tubes in boys has the potential for wide-ranging impact on repairing damage to organs such as the heart. A research team from the Wake Forest Institute for Regenerative Medicine built engineered urethras for five boys, ages 10 to 14, using their own cells. It is the first such success in the world, said Dr. Anthony Atala, the director of the institute. The research was first reported online in the British medical journal Lancet. Story

> The battle against the obesity epidemic has been punctuated by pharmaceutical failures, but that isn't stopping local device and biotechnology companies from jumping into the fat-fighting fray. News

> Sparton Corporation has announced that on March 4, 2011 its wholly owned subsidiary, Sparton BP Medical Denver, LLC completed its previously announced acquisition of certain assets and assumption of certain liabilities of Byers Peak Incorporated. The all-cash transaction is valued at $4.35 million, subject to certain post-closing adjustments. Sparton release

And Finally... U.S. Sen. Bill Nelson (D-FL) and four other Democratic senators unveiled legislation Tuesday designed to crack down on the theft of medical products, including prescription drugs and medical devices. Item